Jin et al[7] revealed the expression of spondin-2 was up-regulation in patients with depth of invasion (T3/T4) and lymph node metastasis (N1-3) indicating higher invasive and metastasizing activity in spondin-2 high-expression cancer cells. The gene discussed is SPON2; the disease is cancer.